Stock AFX CARL ZEISS MEDITEC AG
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Carl Zeiss Meditec AG Berne S.E.

Equities

AFX

DE0005313704

Delayed Berne S.E.
Other stock markets
 12:00:00 2024-04-08 pm EDT 		5-day change 1st Jan Change
104.7 CHF -10.65% Intraday chart for Carl Zeiss Meditec AG -10.65% +12.25%
Jul. 05 DZ Bank Downgrades Carl Zeiss Meditec to Hold from Buy, Cuts PT MT
Jul. 03 Berenberg lowers target for Carl Zeiss Meditec to 71 euros - 'Hold' DP

Summary

  • From a short-term investment perspective, the company presents a deteriorated fundamental situation

Strengths

  • The opinion of analysts covering the stock has improved over the past four months.
  • Historically, the company has been releasing figures that are above expectations.

Weaknesses

  • The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
  • The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 30.65 times its estimated earnings per share for the ongoing year.
  • The company is highly valued given the cash flows generated by its activity.
  • The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
  • The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
  • For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
  • The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
  • Over the past twelve months, analysts' consensus has been significantly revised downwards.
  • The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.

Ratings chart - Surperformance

Sector: Advanced Medical Equipment & Technology

1st Jan change Capi. Investor Rating ESG Refinitiv
CARL ZEISS MEDITEC AG Stock Carl Zeiss Meditec AG
+12.25% 6.31B -
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+1.75% 204B
B
DANAHER CORPORATION Stock Danaher Corporation
+3.42% 178B
B-
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+31.54% 154B
B-
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+32.16% 112B
A-
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
+1.71% 64.32B
A-
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+21.08% 54.88B
B+
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
-1.61% 47.24B
B+
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
-9.11% 36.8B
A
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
-0.34% 35.26B -
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. AFX Stock
  4. AFX Stock
  5. Ratings Carl Zeiss Meditec AG